| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | 530 |
| Total Income - EUR | 0 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | 530 |
| Total Expenses - EUR | 0 | 0 | 23 | - | 0 | 0 | - | 0 | 0 | 9 |
| Gross Profit/Loss - EUR | 0 | 0 | -23 | - | 0 | 0 | - | 0 | 0 | 521 |
| Net Profit/Loss - EUR | 0 | 0 | -23 | - | 0 | 0 | - | 0 | 0 | 439 |
| Employees | 0 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | 0 |
Check the financial reports for the company - Recardia Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | 0 |
| Current Assets | 37.427 | 37.045 | 1.553 | - | 1.495 | 1.467 | - | 1.439 | 1.434 | 1.947 |
| Inventories | 0 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | 0 |
| Receivables | 37.390 | 37.009 | 0 | - | 0 | 0 | - | 0 | 0 | 0 |
| Cash | 36 | 36 | 1.553 | - | 1.495 | 1.467 | - | 1.439 | 1.434 | 1.947 |
| Shareholders Funds | -182 | -180 | -200 | - | -192 | -189 | - | -185 | -184 | 256 |
| Social Capital | 45 | 45 | 44 | - | 42 | 41 | - | 41 | 40 | 40 |
| Debts | 37.609 | 37.225 | 1.753 | - | 1.687 | 1.655 | - | 1.623 | 1.619 | 1.691 |
| Income in Advance | 0 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Recardia Medical Srl